• Skip to primary navigation
  • Skip to main content
  • Skip to footer

SBIRT Training

Clinical Skills Training for Substance Use Problems

  • Home
  • Resources
  • About
  • Contact
  • Log In
All Activities
Price: No Fee

Nursing Tobacco Interventions

Skills to Help Patients Quit

3 hr(s)
Goal: The learner will be able to screen for tobacco use in adolescent and adult patients, provide basic motivational and behavioral tobacco interventions for those not ready to quit, provide pharmacological interventions for those ready to quit, and provide follow-up after providing tobacco interventions.

Have an Enrollment Key? Redeem Now

Log In     Register   Create Group

Activity Steps

Activity Content
Post-Assessments
Certificate

This activity is designed to change: Competence, Performance, Patient Outcome. 3hr(s)

Overview

Professional Practice Gaps

Educational Objectives:

After completing this activity participants will be able to:

  • Screen patients for tobacco use
  • Provide brief counseling interventions for patients who are not ready to quit tobacco and for patients who are ready to quit
  • Use motivational interviewing skills when providing tobacco interventions
  • Recommend or prescribe pharmacological interventions for patients who are quitting tobacco use
  • Follow up appropriately after providing tobacco interventions and intervene for relapse prevention

Modules in this Training Activity

Activity Content

Expand All | Collapse All
Pages Status
1

Nursing Tobacco Pre-Assessments
  • Nursing Tobacco Pre-Survey

2

Nursing Tobacco Interventions — Part I

3

Nursing Tobacco Interventions — Part II

4

Nursing Tobacco Interventions — Time To Quit Vaping

Training Activity References

Audience and Accreditation

Audience: Primary care providers and counselors

Type Est. Time Released Expires
DCBN 3 hr(s) 4/5/21 4/4/23
FBN 3 hr(s) 4/5/21 4/4/23

Arkansas State Board of Nursing Accreditation Statement: Clinical Tools, Inc. is recognized by the Arkansas State Board of Nursing as an accredited provider of continuing medical education for nurses.

DCBN Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 3 hour(s) of DCBN credit. Clinical Tools, Inc. is an approved provider by the District of Columbia Board of Nursing and is registered with CE Broker, Provider #50-1942.

Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling: Clinical Tools, Inc. is recognized by the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling as an accredited provider of continuing medical education.

FBN Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 3 hour(s) of FBN credit. Providers and other health professionals should claim only the credit commensurate with the extent of their participation in the activity.

FBN – Certified Nursing Assistants Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 3 hour(s) of FBN – CNA credit. Providers and other health professionals should claim only the credit commensurate with the extent of their participation in the activity.

Georgia State Board of Nursing Accreditation Statement: Clinical Tools, Inc. is recognized by the Georgia State Board of Nursing as an accredited provider of continuing medical education for nurses.

New Mexico State Board of Nursing Accreditation Statement: Clinical Tools, Inc. is recognized by the New Mexico State Board of Nursing as an accredited provider of continuing medical education for nurses.

South Carolina State Board of Nursing Accreditation Statement: Clinical Tools, Inc. is recognized by the South Carolina State Board of Nursing as an accredited provider of continuing medical education for nurses.

Letter of Completion: A letter of completion for 3 hours is available for non-physicians.

A score of 70% on the post-test is required to complete the activity.

Participation Requirements

Funding
Initial development of this activity was supported by a contract from the National Institute on Drug Abuse (#HHSN271200800038C), a grant from the National Institute on Drug Abuse (#HHSN271200800038C).

Authors

As an ACCME accredited provider of continuing medical education, Clinical Tools, Inc.requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest to the provider. The ACCME defines ‘relevant’ financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Any conflicts of interest are resolved prior to the delivery of the educational activity to the learner. CTI does not permit individuals with financial conflicts of interest to participate in any stage of activity development.

Clinical Tools, MD, MD (Company, Clinical Tools, Inc.)
Disclosure: Has no relevant financial relationship(s) with ineligible companies to disclose. 
Read Bio
Clinical Tools, Inc. (CTI) is a small, physician-run business dedicated to harnessing the potential of the Internet to create scalable, usable, and broadly available tools to improve the ability of physicians and other health care providers to care for patients. We achieve this goal by providing education and training to students and professionals and creating Web-based support tools for clinicians, researchers, and consumers. Information technology can and should serve as a stable framework that supports researchers and clinicians in their roles. We provide dissemination and management tools that empower clinicians and consumers to understand and control the vast amount of information related to making individual health choices. We serve our clients creatively, effectively, and with the highest quality of service.

Most Recent Reviews

CTI Content Review: Mon, 10/28/2019
CTI Editorial Review: Mon, 10/28/2019

Funding Information Development of this website was funded entirely by grant #R44DA12066 and contract #HHSN271200655304C from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc. No commercial support is received.
Clinical Tools is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

  • Contact Us
  • Copyright & Reproduction Guidelines
  • Privacy Policy
  • Terms of Service
  • Technology Requirements
  • 508 Compliance

Footer

developed & maintained by
ClinicalTools

A member of The Clinical Encounters Training Group: SBIRT Training | BupPractice | PainTx Challenge | CE:Vaping | CE:Alcohol | CE:Obesity | OpioidCME

Clinical Tools, Inc. staff have disclosed no relevant financial relationships.

Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.
This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions.
  • Facebook
  • LinkedIn
  • Twitter
feedback@clinicaltools.com

101 A Market St Chapel Hill, NC 27516
919-960-8118

Contact Us

© 2023 · Clinical Tools, Inc · Log in

Professional Practice Gaps

Tobacco use is still fairly common; in the United States. In 2020, 20.7% of the U.S. population over age 12 used tobacco or engaged in nicotine vaping in the past month, according to 2020 National Survey on Drug Use and Health data (SAMHSA, 2022). The form used most often was still cigarettes (15% of the population), followed by cigars (3.8%), and nicotine vaping (3.8%).

Tobacco use in the form of smoking and secondhand smoke is estimated to be responsible for more than 480,000 premature deaths annually (CDC, 2019) and causes significant morbidity (USDHHS, 2020). The effectiveness of tobacco interventions by health care providers was evaluated in a review of the literature by the review panel for the U.S. Public Health Service Clinical Practice Guideline, Treating Tobacco Use and Dependence: 2008 Update (Fiore, et al., 2008). They found that medication and counseling are more effective for promoting tobacco cessation than no treatment and that intervention effectiveness increases with increased intervention intensity. The Clinical Practice Guideline (Fiore, et al., 2008), also provided evidence-based guidelines for clinicians on how to provide brief and more extensive interventions in tobacco use.  These basic guidelines continue to prove to be effective with minor changes, particularly to include a few newer pharmacological treatments and note some associated precautions (USPSTF, 2021; Berkowitz et al., 2022).

Despite the documented need for tobacco cessation and the effectiveness of clinical interventions and the availability of practice guidelines, many health providers are not providing evidence-based tobacco interventions. A focus group of 30 NYC physicians found that only 60% had formal training in treating tobacco dependence/use (Kilgore et al, 2021). Many physicians studied had a low level of confidence in the efficacy of approved medications. While they mostly understood the risks of smoking and the basics of counseling and prescribing medications, not all physicians were treating smoking and those who were, often were not following guidelines. Barriers reported included insufficient time and reimbursement. Many of the primary care participants reported not feeling adequately trained to provide behavior change counseling that is needed. Another study that observed 38 physicians during counseling confirmed that counseling skills needed improving, in particular, the use of empathy and evoking the patient’s ideas and feelings (Champassak et al., 2014).

Training health care professionals in evidence-based, brief tobacco interventions in order to assure that all health providers know and are confident to provide tobacco interventions will help address this practice gap.

Practice Gap References

  • Berkowitz D, Park J, Rupp K, et al. Tobacco Control Network: 2022 Policy Recommendations Guide. 2022:50.
  • CDC. Smoking and Tobacco Use. Fast Facts. Updated November 2019. Available at: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm
  • Champassak SL, Catley D, Finocchario-Kessler S, et al. Physician smoking cessation counseling and adherence to a clinical practice guideline. Eur J Pers Cent Healthc. 2014;2(4):477-484. doi:10.5750/ejpch.v2i4.833. PMCID: PMC4533879. PMID: 26279853.
  • Department of Health and Human Services (USDHHS). The Health Consequences of Smoking: A Report of the Surgeon General. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Washington, D.C.: For sale by the Supt. of Docs., U.S. G.P.O.. 2004. Available at: https://www.cdc.gov/tobacco/data_statistics/sgr/2004/complete_report/index.htm/index.htm Accessed on: 2014-04-28.
  • Fiore MC, Bailey WC, Cohen SJ, et al. Clinical Practice Guideline: Treating Tobacco Use and Dependence. Rockville, Md: Public Health Service, US Dept of Health and Human Services. 2000.
  • Kilgore EA, Waddell EN, Tannert Niang KM, Murphy J, Thihalolipavan S, Chamany S. Provider Attitudes and Practices on Treating Tobacco Dependence in New York City After 10 years of Comprehensive Tobacco Control Efforts. J Prim Care Community Health. February 23, 2021;12:2150132720957448. doi:10.1177/2150132720957448. PMCID: PMC7907932. PMID: 33622072.
  • National Center for Chronic Disease Prevention and Health Promotion. Targeting tobacco use: the nation’s leading cause of death, at-a-glance. CDC Web site. 2010. Available at: https://stacks.cdc.gov/view/cdc/5527 Accessed on: 2016-09-06.
  • Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality; 2022.
  • USDHHS. Smoking Cessation. A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020. https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf. Accessed February 5, 2020.
  • US Preventive Services Task Force. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA. January 19, 2021;325(3):265-279. doi:10.1001/jama.2020.25019.
Register
  • If you already have an account on one of our other Clinical Encounters sites, you do not need to create a new account, simply log in.
  • Hidden
  • Hidden
  • By registering, you agree to the Terms of Service and Privacy Policy. If you are a part of a group, you understand your participation information can be provided to the group organizer.
  • This field is for validation purposes and should be left unchanged.

Log In

Forgot Password?

 

Don’t have an account?
Register now!

Training Activity References
  • AHFS. Varenicline. Drugs.com. 2000-2014. Available at: https://www.drugs.com/monograph/chantix.html Accessed on: 2010-06-25.
    Alberta Health Services . Brief Tobacco Intervention: Ready 2 Quit . YouTube . 2012. Available at: https://www.youtube.com/watch?v=Z4B74E_8ncc Accessed on: 2015-04-27.
  • American Academy of Family Physicians. HCPCS, CPT, & ICD-9 Codes Related to Tobacco Cessation Counseling. AAFP.org. 2011. Available at: http://www.integration.samhsa.gov/images/res/Coding-list.pdf Accessed on: 2013-10-28.
  • American Academy of Family Physicians. HCPCS, CPT, & ICD-9 Codes Related to Tobacco Cessation Counseling. Ask and Act: A Tobacco Cessation Program. 2010. Available at: http://www.integration.samhsa.gov/images/res/Coding-list.pdf Accessed on: 2014-11-06.
  • American Academy of Pediatrics. Policy statement. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011; 128(5): e1330-e1340. Available at: http://pediatrics.aappublications.org/content/128/5/e1330.full Accessed on: 2011-12-13.
  • American Cancer Society. Guide for quitting smoking. American Cancer Society Website. 2009. Available at: https://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/guide-to-quitting-smoking-toc Accessed on: 2010-06-23.
  • American Lung Association. Helping Smokers Quit: Tobacco Cessation Coverage 2011.
  • American Lung Association. Fighting for Air. 2011. Available at: http://www.lung.org/stop-smoking/help-someone-quit/ Accessed on: 2012-02-02.
  • American Society of Health-System Pharmacists. Medline Plus – Trusted Health Information for You. Medline Plus – Trusted Health Information for You. 2014. Available at: https://www.nlm.nih.gov/medlineplus/druginformation.html Accessed on: 2014-04-28.
  • Audrain-McGovern J, Benowitz NL. Cigarette Smoking, Nicotine, and Body Weight. Clin Pharmacol Ther. 2011; 90: 164-168. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195407/ Accessed on: 2014-10-23.
  • Babb S, Melarcher A, Schauer G, et al.. Quitting Smoking Among Adults — United States, 2000–2015. Morbidity and Mortality Weekly Report (MMWR). 2017; 65(52): 1457–1464. Available at: https://www.cdc.gov/mmwr/volumes/65/wr/mm6552a1.htm?s_cid=mm6552a1_e Accessed on: 2017-01-09.
  • Bader P, McDonald P, Selby P. An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tob Control. 2009; 18: 34-42. Available at: http://tobaccocontrol.bmj.com/content/18/1/34.full.pdf Accessed on: 2010-08-26.
  • Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry. 1992; 149: 464-469. Available at: https://www.ncbi.nlm.nih.gov/pubmed/1554030 Accessed on: 2013-10-28.
  • CDC. Planning and Implementing Screening and Brief Intervention for Risk Alcohol Use: A Step-by-Step Guide for Primary Care Providers. National Center on Birth Defects and Developmental Disabilities. 2014. Available at: https://www.cdc.gov/ncbddd/fasd/documents/alcoholsbiimplementationguide.pdf Accessed on: 2014-12-16.
  • CDC. Tobacco Use and Pregnancy . CDC’s Division of Reproductive Health. 2014. Available at: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/tobaccousepregnancy/index.htm Accessed on: 2014-12-16.
  • Center for Disease Control and Prevention. Secondhand Smoke Fact Sheet. CDC Website. 2010. Available at: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/secondhand_smoke/general_facts/index.htm Accessed on: 2010-06-15.
  • Center Watch. Chantix® (varenicline) receives FDA approval. Center Watch. 2000-2014. Available at: http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/897/chantix-varenicline Accessed on: 2014-04-28.
  • Centers for Disease Control and Prevention. Current Cigarette Smoking Among Adults in the United States. Smoking and Tobacco Use. CDCP Website. Content source: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion. 2016; December 1: . Available at: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/ Accessed on: 2017-01-09.
  • Centers for Disease Control and Prevention. Current Cigarette Smoking Among Adults — United States, 2005–2014. Morbidity and Mortality Weekly Report. 2015; 64(44): 1233-1240. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6444a2.htm?s_cid=mm6444a2_e Accessed on: 2015-11-12.
  • Centers for Disease Control and Prevention. Tobacco Use: Targeting the Nation’s Leading Killer. CDC Website. 2011. Available at: http://stacks.cdc.gov/view/cdc/5527/
  • Centers for Medicare & Medicaid Services. Medicaid Benefits: Prevention. Medicaid.gov. 2014. Available at: https://www.medicaid.gov/medicaid/benefits/prevention/index.html Accessed on: 2014-11-06.
  • Centers for Medicare & Medicaid Services. New Medicaid Tobacco Cessation Services. CMS. 2011. Available at: https://downloads.cms.gov/cmsgov/archived-downloads/SMDL/downloads/SMD11-007.pdf Accessed on: 2012-02-14.
  • Clinical Tools, Inc.. Motivational Interviewing. Clinical Tools, Inc.. 2016. Available at: https://www.youtube.com/embed/4_q9WPTnO4k Accessed on: 2016-01-08.
  • Department of Health and Human Services (USDHHS). The Health Consequences of Smoking: A Report of the Surgeon General. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Washington, D.C.: For sale by the Supt. of Docs., U.S. G.P.O.. 2004. Available at: https://www.cdc.gov/tobacco/data_statistics/sgr/2004/complete_report/index.htm/index.htm Accessed on: 2014-04-28.
  • Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, Rigotti N, Sachs DP. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics. 2002; 24(4): 540-551. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12017399 Accessed on: 2013-10-28.
  • Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of Periodontitis in Adults in the United States: 2009 and 2010. Journal of Dental Research. 2012; 91: 914-20. Available at: http://jdr.sagepub.com/content/91/10/914 Accessed on: 2014-12-16.
  • FDA. Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease. FDA Safety Communication. 2011. Available at: https://www.fda.gov/Drugs/DrugSafety/ucm259161.htm Accessed on: 2014-04-28.
  • Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008. Available at: https://www.ncbi.nlm.nih.gov/books/NBK63952/ Accessed on: 2013-09-26.
  • GlaxoSmithKline. Nicoderm CQ (nicotine) patch, extended release. DailyMed. 2012. Available at: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93b2d1b9-83c1-40b5-b6af-90c38c8d6cef Accessed on: 2013-10-28.
  • GlaxoSmithKline. Nicorette (nicotine polacrilex) gum, chewing . DailyMed. 2013. Available at: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=673fd19f-69b3-4f73-b9b4-18b5f4cbf69c Accessed on: 2013-10-28.
  • GlaxoSmithKline. NICORETTE (nicotine polacrilex) lozenge. DailyMed. 2012. Available at: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdee1637-8049-4bc5-b196-b6d854c9f9f3 Accessed on: 2013-10-28.
  • GlaxoSmithKline. ZYBAN® (bupropion hydrochloride) Sustained-Release Tablets . GSK. 2012. Available at: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Zyban/pdf/ZYBAN-PI-MG.PDF Accessed on: 2013-12-05.
  • Glynn TJ, Manley MW. How to help your patients stop smoking- a National Cancer Institute manual for physicians. Smoking and Tobacco Control Program, National Cancer Institute, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. Bethesda, MD. 1998. Available at: http://books.google.com/books/about/How_to_help_your_patients_stop_smoking.html?id=TM1pAAAAMAAJ
  • Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. A randomized controlled trial. JAMA. 2006; 296(1): 47-55. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16820546 Accessed on: 2014-04-28.
  • Jensen CD, Cushing CC, Aylward BS, Craig JT, Sorell DM, Steele RG. Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: A meta-analytic review. J of Consulting and Clinical Psychology. 2011; 79(4): 443-40. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21728400 Accessed on: 2013-10-24.
  • Kozink RV, Lutz AM, Rose JE, Froeliger B, McClernon FJ. Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition. Addiction Biology. 2010; 15: 480-490. Available at: http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2010.00252.x/full Accessed on: 2014-10-23.
  • Lai DTC, Cahill K, Qin Y, Tang JL. Motivational interviewing for smoking cessation (Review). The Cochrane Collaboration. 2010. Available at: https://www.ncbi.nlm.nih.gov/pubmed/20091612 Accessed on: 2015-04-20.
    Medicare Learning Network. “Incident to” Services. Medicare Learning Network. 2013. Available at: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-NetworkMLN/MLNMattersArticles/downloads/se0441.pdf Accessed on: 2014-11-06.
  • Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. The Guilford Press. 2013. Available at: http://www.amazon.com/Motivational-Interviewing-Third-Edition-Applications/dp/1609182278 Accessed on: 2014-10-10.
  • Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O’Connell TN, Zandi KS, Miller S, Coe JW. Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos. 2006; 34(1): 121-30. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16221753 Accessed on: 2013-10-28.
  • Parrott A.C. Nesbitt’s Paradox resolved? Stress and arousal modulation during cigarette smoking . Addiction. 1993; 93(1): 27-39. Available at: https://www.ncbi.nlm.nih.gov/pubmed/9624709 Accessed on: 2013-10-28.
  • PDR Staff. Physician’s Desk Reference. Thomson Healthcare. 2003. Available at: http://www.pdr.net/ Accessed on: 2013-10-28.
  • Resnicow K, McMaster F. Motivational Interviewing: moving from why to how with autonomy support. Int J Behav Nutr Phys Act.. 2012; 9: . Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330017/ Accessed on: 2014-10-13.
  • Shiffman CH, Jarvick ME. Smoking withdrawal symptoms in two weeks of abstinence. Journal of Psychopharmacology. 1976; 50(1): 35-39. Available at: https://www.ncbi.nlm.nih.gov/pubmed/827760 Accessed on: 2013-10-28.
  • Shiffman S, Dresler CM, Hajek P, Gilburt SJA, Targett DA, Strahs KR. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med. 2002; 62: 1267-1276. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12038945 Accessed on: 2013-10-28.
  • Siu AL, U.S. Preventive Services Task Force. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: A review of reviews for the U.S. Preventive Services Task Force. Ann Intern Med. 2015. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26389730 Accessed on: 2016-02-09.
  • Smedslund G, Berg RC, Hammerstrøm TK, Steirol A, Leiknes KA, Dahl HM, Karlsen K. Motivational interviewing for substance abuse . The Cochrane Library. 2011. Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008063.pub2/abstract Accessed on: 2014-10-30.
  • Sobell LC, Sobell MB, Agrawal S. Self-change and dual recoveries among individuals with alcohol and tobacco problems: current knowledge and future directions. Alcohol Clinical Experimental Research. 2002; (12): 1936-1938. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12500127 Accessed on: 2013-10-28.
  • Stotts AL, Schmitz JM, Grabowski J. Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both?. Drug and Alcohol Dependence. 2003; 69: 1-7. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12536060 Accessed on: 2013-10-28.
  • Texas Department of State Health. Billing Codes Guide. Yes You Can. 2011. Available at: http://www.yesquit.org/downloads/guides/BillingCodesGuide.pdf Accessed on: 2014-11-06.
  • Tobacco Control Legal Consortium. The Mental Health Parity and Addiction Equity Act and the Affordable Care Act. SAMHSA. 2011. Available at: http://www.integration.samhsa.gov/health-wellness/The_Mental_Health_Parity_and_Addiction_Equity_Act.pdf Accessed on: 2012-02-02.
  • Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation. A randomized controlled trial. JAMA. 2006; 296(1): 64-71. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16820548 Accessed on: 2013-10-28.
  • Tran K , Asakawa K, Cimon K, Moulton K, Kaunelis D, Pipe A, Selby P. Pharmacologic-based strategies for smoking cessation: clinical and cost-effectiveness analyses. Canadian Agency for Drugs and Technologies in Health (CADTH). 2012. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442619/ Accessed on: 2013-10-28.
  • U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. 2013. Available at: https://nccd.cdc.gov/uscs/ Accessed on: 2013-10-28.
  • U.S. Department of Health & Human Services. Cigarette Smoke Affects Your Body. Be Tobacco Free.gov. 2014. Available at: https://betobaccofree.hhs.gov/health-effects/smoking-health/ Accessed on: 2014-12-16.
  • U.S. Department of Health and Human Services (USDHHS). Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Ga: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Dept of Health and Human Services. 2000. Available at: https://www.cdc.gov/tobacco/data_statistics/sgr/2000/complete_report/index.htm Accessed on: 2013-10-28.
  • U.S. Department of Health and Human Services. Alcohol Alert: Alcohol and Tobacco. Alcohol Alert. 2007. Available at: https://pubs.niaaa.nih.gov/publications/AA71/AA71.pdf Accessed on: 2014-10-10.
  • U.S. Department of Health and Human Services.. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. . Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention . 2014. Available at: https://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm Accessed on: 2014-04-28.
  • U.S. Food and Drug Administration. FDA Approves Novel Medication for Smoking Cessation. FDA Website. Press release, 11 May 2006. Available at: https://www.fda.gov/NewsEvents%2FNewsroom%2FPressAnnouncements%2F2006%2Fucm108651.htm Accessed on: 2010-06-15.
  • U.S. Food and Drug Administration. Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics). FDA Alert. 2009b. Available at: https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm169986.htm Accessed on: 2014-04-28.
  • U.S. Preventative Services Task Force, Moyer VA. Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse: U.S. Preventative Services Task Force Recommendation Statement. Annals of Internal Medicine. 2013. Available at: http://www.integration.samhsa.gov/sbirt/USPSTF_Screening_forAlcohol_5_13_13_0000605-201308060-00652.pdf Accessed on: 2014-12-16.
  • Walters ST, Rotgers F. Treating Substance Abuse: Theory and Technique. The Guilford Press. 2011. Available at: https://www.guilford.com/books/Treating-Substance-Abuse/Walters-Rotgers/9781462513512 Accessed on: 2014-10-13.
  • West R, Hajek P. What happens to anxiety levels on giving up smoking?. American Journal Psychiatry. 1997; 154: 1589-1592. Available at: https://www.ncbi.nlm.nih.gov/pubmed/9356569 Accessed on: 2013-10-28.
Participation Requirements

Activity Credit: Obtaining credit for participation in this activity requires that you complete the pre-assessments, work through the modules (including all in-module interactive activities), complete the post-assessments with a 70% score on the post-test, and then request credit. At the end of the activity, you will be instructed on how to print out a certificate for your records.

Time Requirement: Keep track of the amount of time it takes you to complete this activity. You will be required to spend a set amount of time in order to claim credit. You should claim credit only for the time actually spent in the activity.

Technical Requirement: Our site requires the latest versions of Google Chrome, Safari, Firefox, or Microsoft Edge. The site is not optimized for Internet Explorer and certain functionality will not work with that browser. Please utilize a supported browser when accessing the site.